(Q43889031)

27 November 2017

High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). (English)

1 reference

27 November 2017

1 reference

acute myeloid leukemia

1 reference

T Köhler

1

1 reference

27 November 2017

C Schill

2

1 reference

27 November 2017

M W Deininger

3

1 reference

27 November 2017

R Krahl

4

1 reference

27 November 2017

S Borchert

5

1 reference

27 November 2017

D Hasenclever

6

1 reference

27 November 2017

S Leiblein

7

1 reference

27 November 2017

O Wagner

8

1 reference

27 November 2017

D Niederwieser

9

1 reference

27 November 2017

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

16

1 reference

27 November 2017

1

1 reference

27 November 2017

22-29

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402340

27 November 2017

0 references

cites work

The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

MULTIDRUG RESISTANCE IN LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Dissecting the pathways to death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Expression of apoptosis-controlling proteins in acute leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Investigation of the expression of housekeeping genes in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

High bax expression is a good prognostic indicator in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Antisense inhibition of Bax mRNA increases survival of terminally differentiated HL60 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Cytokines, molecular biological abnormalities, and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402340

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402340

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference